Aurobindo Pharma has reported profit after tax of Rs 188.6 crore for the quarter ended December 2010, up 10% as compared to Rs 172 crore in same period the previous year.
Revenues went up by 30.3% to Rs 1,192 crore from Rs 915 crore (YoY). Operating profit margin was flat at 26.8% versus 26.5%. The company has received forex gain of Rs 4.08 crore as against Rs 24.81 crore on year-on-year basis. Interest costs declined at Rs 11.46 crore from Rs 12.66 crore.Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
